Lars Holtug
CIK: 0001965626
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (100.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About HOLTUG LARS
HOLTUG LARS (SEC CIK 0001965626) files insider reports with the SEC as Director of Ascendis Pharma A/S (ASND) and Director of Evaxion A/S (EVAX).
Signal8 holds 3 ownership filings by HOLTUG LARS (2 Form 3, 1 Form 4), filed between Mar 18, 2026 and Sep 3, 2026. Those filings report 1 transaction, the latest on Sep 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on HOLTUG LARS's filings is in HELLERUP.
Recent filings by HOLTUG LARS
- Sep 2, 2026: Open-market sale of ASND shares (Form 4, code S).
Other insiders filing for Ascendis Pharma A/S (ASND)
- BIENAIME JEAN JACQUES, Director
- Bodenhoff Mads, SVP & PAO
- SMITH SCOTT THOMAS, EVP & Chief Financial Officer
- JENSEN FLEMMING STEEN
- Fairey William, Director
- IMANI SIHAM, Director